Matches in Nanopublications for { ?s <http://www.w3.org/2000/01/rdf-schema#label> ?o ?g. }
- list-rest label "List-Rest" assertion.
- class2 label "URI of existing class 2" assertion.
- name label "the name of the class" assertion.
- class1 label "URI of existing class 1" assertion.
- description label "description of the class" assertion.
- newclass label "short ID of new class" assertion.
- list label "List" assertion.
- assertion label "Defining a new class by intersection or union" assertion.
- description label "description of the class" assertion.
- restrictiontype label "select type of restriction" assertion.
- newclass label "short ID of new class" assertion.
- property label "the property on which the restriction is applied" assertion.
- name label "the name of the class" assertion.
- class label "URI of existing class" assertion.
- assertion label "Defining a new class by a property restriction" assertion.
- cohort label "Elderly" assertion.
- association label "Currently, no medication has been approved for use in the USA for cognition in DLB but there is class I evidence suggesting that donepezil and rivastigmine improve cognition and global function ]" assertion.
- step label "An awesome step for creating composite image by blending images using a transparency mask" assertion.
- out1 label "out1" assertion.
- image1 label "image1" assertion.
- image2 label "image2" assertion.
- LinguisticSystem label "python" assertion.
- cohort label "Elderly" assertion.
- association label "Memantine had a positive impact on global impression and behavioral symptoms, but its efficacy on cognitive function is less clear" assertion.
- _1 label "RNaseZAPTM wipes" assertion.
- step label "Put here a name of your awesome step (include the word awesome so others will find it)" assertion.
- LinguisticSystem label "python" assertion.
- out1 label "out1" assertion.
- image label "image" assertion.
- association label "An increasing body of evidence supports melatonin as the safest choice for children with NDDs." assertion.
- cohort label "Children" assertion.
- MONDO_0013600 label "insomnia (disease)" assertion.
- MONDO_0013600 label "insomnia (disease)" assertion.
- MONDO_0013600 label "insomnia (disease)" assertion.
- MONDO_0013600 label "insomnia (disease)" assertion.
- MONDO_0013600 label "insomnia (disease)" assertion.
- MONDO_0013600 label "insomnia (disease)" assertion.
- MONDO_0013600 label "insomnia (disease)" assertion.
- MONDO_0013600 label "insomnia (disease)" assertion.
- MONDO_0013600 label "insomnia (disease)" assertion.
- MONDO_0013600 label "insomnia (disease)" assertion.
- MONDO_0013600 label "insomnia (disease)" assertion.
- MONDO_0013600 label "insomnia (disease)" assertion.
- MONDO_0013600 label "insomnia (disease)" assertion.
- MONDO_0013600 label "insomnia (disease)" assertion.
- MONDO_0013600 label "insomnia (disease)" assertion.
- MONDO_0013600 label "insomnia (disease)" assertion.
- MONDO_0013600 label "insomnia (disease)" assertion.
- MONDO_0013600 label "insomnia (disease)" assertion.
- MONDO_0013600 label "insomnia (disease)" assertion.
- MONDO_0013600 label "insomnia (disease)" assertion.
- MONDO_0013600 label "insomnia (disease)" assertion.
- MONDO_0013600 label "insomnia (disease)" assertion.
- MONDO_0013600 label "insomnia (disease)" assertion.
- MONDO_0013600 label "insomnia (disease)" assertion.
- MONDO_0013600 label "insomnia (disease)" assertion.
- MONDO_0013600 label "insomnia (disease)" assertion.
- MONDO_0013600 label "insomnia (disease)" assertion.
- MONDO_0013600 label "insomnia (disease)" assertion.
- MONDO_0013600 label "insomnia (disease)" assertion.
- MONDO_0013600 label "insomnia" assertion.
- association label "Paroxetine is not FDA approved for use in children and adolescents less than 18 years of age; however, clinicians do use off-label in this group." assertion.
- cohort label "Children and adolescents" assertion.
- cohort label "Adults" assertion.
- association label "Paroxetine is not FDA approved for use in children and adolescents less than 18 years of age; however, clinicians do use off-label in this group." assertion.
- association label "Paroxetine is not FDA approved for use in children and adolescents less than 18 years of age; however, clinicians do use off-label in this group." assertion.
- cohort label "Adults" assertion.
- cohort label "Adults" assertion.
- association label "Paroxetine is not FDA approved for use in children and adolescents less than 18 years of age; however, clinicians do use off-label in this group." assertion.
- association label "There are other off-label uses of imipramine as in the treatment of chronic neuropathic pain and panic disorder." assertion.
- cohort label "Adults" assertion.
- association label "This profile suggests that asenapine may be of particular value off label for bipolar depression, anxiety, and aggression." assertion.
- cohort label "Adults" assertion.
- cohort label "Children" assertion.
- association label "Antihistamine agents, such as hydroxyzine or diphenhy- dramine, are the most widely prescribed sedatives in the pediatric practice but evidence supporting their use is still limited." assertion.
- association label "Limited evidence supports the use of alpha-agonists such as clonidine to improve sleep onset latency, especially in attention deficit/hyperactivity disorder subjects." assertion.
- cohort label "Children" assertion.
- cohort label "Children" assertion.
- association label "Only few studies have been carried out in children’s and adolescents’ zolpidem, zaleplon, and eszopiclone, with contrasting results." assertion.
- cohort label "Children" assertion.
- association label "A small randomized and placebo-controlled study of quetiapine (25 mg/nocte, a relatively low dose) in adults showed a statistically nonsignificant trend toward improvement in total sleep time and reduced sleep latency (Tassniyom, Paholpak, Tassniyom, & Kiewyoo, 2010)." assertion.
- COVID-KG label "COVID KG" assertion.
- COVID-KG label "COVID KG" assertion.
- M4M-metadata label "M4M metadata workshop" assertion.
- M4M-metadata label "M4M metadata workshop" assertion.
- M4M-metadata label "M4M metadata workshop" assertion.
- M4M-metadata label "M4M metadata workshop" assertion.
- M4M-metadata label "M4M metadata workshop" assertion.
- R4RM4M label "R4RM4M workshop" assertion.
- R4RM4M label "R4RM4M workshop" assertion.
- R4RM4M label "R4RM4M workshop" assertion.
- R4RM4M label "R4RM4M workshop" assertion.
- R4RM4M label "R4RM4M workshop" assertion.
- M4M-infrastructure label "M4M infrastructure workshop" assertion.
- M4M-infrastructure label "M4M infrastructure workshop" assertion.
- M4M-infrastructure label "M4M infrastructure workshop" assertion.
- M4M-infrastructure label "M4M infrastructure workshop" assertion.
- M4M-infrastructure label "M4M infrastructure workshop" assertion.
- M4M-FIP label "M4M FIP workshop" assertion.
- M4M-FIP label "M4M FIP workshop" assertion.